Literature DB >> 11154975

A rapid and systematic review of the clinical effectiveness and cost-effectiveness of glycoprotein IIb/IIIa antagonists in the medical management of unstable angina.

M S McDonagh1, L M Bachmann, S Golder, J Kleijnen, G ter Riet.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11154975

Source DB:  PubMed          Journal:  Health Technol Assess        ISSN: 1366-5278            Impact factor:   4.014


× No keyword cloud information.
  3 in total

1.  National Institute for Clinical Excellence (NICE): Is economic appraisal working?

Authors:  Adrian Towse; Clive Pritchard
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

Review 2.  Antiplatelet treatment in unstable angina: aspirin, clopidogrel, glycoprotein IIb/IIIa antagonist, or all three?

Authors:  S A Harding; N A Boon; A D Flapan
Journal:  Heart       Date:  2002-07       Impact factor: 5.994

3.  Economic evaluation of the impact of nicorandil in angina (IONA) trial.

Authors:  A Walker; J McMurray; S Stewart; W Berger; A D McMahon; H Dargie; K Fox; S Hillis; N J K Henderson; I Ford
Journal:  Heart       Date:  2006-05       Impact factor: 5.994

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.